Cargando…

Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads

[Image: see text] Six flavonoids present in Pulicaria jaubertii, i.e., 7,3′-di-O-methyltaxifolin (1), 3′-O-methyltaxifolin (2), 7-O-methyltaxifolin (3), taxifolin (4), 3-O-methylquercetin (5), and quercetin (6), were tested for their anticancer activities. The methylated flavonoids, compounds 1–3 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Hamdoon A., Almahmoud, Suliman A., El-Ghaly, El-Sayed M., Khan, Firdos Alam, Emwas, Abdul-Hamid, Jaremko, Mariusz, Almulhim, Fatimah, Khan, Riaz A., Ragab, Ehab A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774329/
https://www.ncbi.nlm.nih.gov/pubmed/36570308
http://dx.doi.org/10.1021/acsomega.2c05565
_version_ 1784855381052227584
author Mohammed, Hamdoon A.
Almahmoud, Suliman A.
El-Ghaly, El-Sayed M.
Khan, Firdos Alam
Emwas, Abdul-Hamid
Jaremko, Mariusz
Almulhim, Fatimah
Khan, Riaz A.
Ragab, Ehab A.
author_facet Mohammed, Hamdoon A.
Almahmoud, Suliman A.
El-Ghaly, El-Sayed M.
Khan, Firdos Alam
Emwas, Abdul-Hamid
Jaremko, Mariusz
Almulhim, Fatimah
Khan, Riaz A.
Ragab, Ehab A.
author_sort Mohammed, Hamdoon A.
collection PubMed
description [Image: see text] Six flavonoids present in Pulicaria jaubertii, i.e., 7,3′-di-O-methyltaxifolin (1), 3′-O-methyltaxifolin (2), 7-O-methyltaxifolin (3), taxifolin (4), 3-O-methylquercetin (5), and quercetin (6), were tested for their anticancer activities. The methylated flavonoids, compounds 1–3 and 5, were evaluated for their anticancer activities in comparison to the non-methylated parent flavonoids taxifolin (4) and quercetin (6). The structures of the known compounds were reconfirmed by spectral analyses using (1)H and (13)C NMR data comparisons and HRMS spectrometry. The anticancer activity of these compounds was evaluated in colon cancer, HCT-116, and noncancerous, HEK-293, cell lines using the MTT antiproliferative assays. The caspase-3 and caspase-9 expressions and DAPI (4′, 6-diamidino-2-phenylindole) staining assays were used to evaluate the apoptotic activity. All the compounds exhibited antiproliferative activity against the HCT-116 cell line with IC(50) values at 33 ± 1.25, 36 ± 2.25, 34 ± 2.15, 32 ± 2.35, 34 ± 2.65, and 36 ± 1.95 μg/mL for compounds 1 to 6, respectively. All the compounds produced a significant reduction in HCT-116 cell line proliferation, except compounds 2 and 6. The viability of the HEK-293 normal cells was found to be significantly higher than the viability of the cancerous cells at all of the tested concentrations, thus suggesting that all the compounds have better inhibitory activity on the cancer cell line. Apoptotic features such as chromatin condensation and nuclear shrinkage were also induced by the compounds. The expression of caspase-3 and caspase-9 genes increased in HCT-116 cell lines after 48 h of treatment, suggesting cell death by the apoptotic pathways. The molecular docking studies showed favorable binding affinity against different pro- and antiapoptotic proteins by these compounds. The docking scores were minimum as compared to the caspase-9, caspase-3, Bcl-xl, and JAK2.
format Online
Article
Text
id pubmed-9774329
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-97743292022-12-23 Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads Mohammed, Hamdoon A. Almahmoud, Suliman A. El-Ghaly, El-Sayed M. Khan, Firdos Alam Emwas, Abdul-Hamid Jaremko, Mariusz Almulhim, Fatimah Khan, Riaz A. Ragab, Ehab A. ACS Omega [Image: see text] Six flavonoids present in Pulicaria jaubertii, i.e., 7,3′-di-O-methyltaxifolin (1), 3′-O-methyltaxifolin (2), 7-O-methyltaxifolin (3), taxifolin (4), 3-O-methylquercetin (5), and quercetin (6), were tested for their anticancer activities. The methylated flavonoids, compounds 1–3 and 5, were evaluated for their anticancer activities in comparison to the non-methylated parent flavonoids taxifolin (4) and quercetin (6). The structures of the known compounds were reconfirmed by spectral analyses using (1)H and (13)C NMR data comparisons and HRMS spectrometry. The anticancer activity of these compounds was evaluated in colon cancer, HCT-116, and noncancerous, HEK-293, cell lines using the MTT antiproliferative assays. The caspase-3 and caspase-9 expressions and DAPI (4′, 6-diamidino-2-phenylindole) staining assays were used to evaluate the apoptotic activity. All the compounds exhibited antiproliferative activity against the HCT-116 cell line with IC(50) values at 33 ± 1.25, 36 ± 2.25, 34 ± 2.15, 32 ± 2.35, 34 ± 2.65, and 36 ± 1.95 μg/mL for compounds 1 to 6, respectively. All the compounds produced a significant reduction in HCT-116 cell line proliferation, except compounds 2 and 6. The viability of the HEK-293 normal cells was found to be significantly higher than the viability of the cancerous cells at all of the tested concentrations, thus suggesting that all the compounds have better inhibitory activity on the cancer cell line. Apoptotic features such as chromatin condensation and nuclear shrinkage were also induced by the compounds. The expression of caspase-3 and caspase-9 genes increased in HCT-116 cell lines after 48 h of treatment, suggesting cell death by the apoptotic pathways. The molecular docking studies showed favorable binding affinity against different pro- and antiapoptotic proteins by these compounds. The docking scores were minimum as compared to the caspase-9, caspase-3, Bcl-xl, and JAK2. American Chemical Society 2022-12-07 /pmc/articles/PMC9774329/ /pubmed/36570308 http://dx.doi.org/10.1021/acsomega.2c05565 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mohammed, Hamdoon A.
Almahmoud, Suliman A.
El-Ghaly, El-Sayed M.
Khan, Firdos Alam
Emwas, Abdul-Hamid
Jaremko, Mariusz
Almulhim, Fatimah
Khan, Riaz A.
Ragab, Ehab A.
Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads
title Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads
title_full Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads
title_fullStr Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads
title_full_unstemmed Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads
title_short Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads
title_sort comparative anticancer potentials of taxifolin and quercetin methylated derivatives against hct-116 cell lines: effects of o-methylation on taxifolin and quercetin as preliminary natural leads
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774329/
https://www.ncbi.nlm.nih.gov/pubmed/36570308
http://dx.doi.org/10.1021/acsomega.2c05565
work_keys_str_mv AT mohammedhamdoona comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads
AT almahmoudsulimana comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads
AT elghalyelsayedm comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads
AT khanfirdosalam comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads
AT emwasabdulhamid comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads
AT jaremkomariusz comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads
AT almulhimfatimah comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads
AT khanriaza comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads
AT ragabehaba comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads